Clinical implications of tumor‐based next‐generation sequencing in high‐grade epithelial ovarian cancerKatherine Foster, Anil K. Sood, Nicole D. Fleming et al.|Cancer|2023Cited by 9
A pioneering artificial intelligence tool to predict treatment outcomes in ovarian cancer via diagnostic laparoscopyXiaotian Ma, Shayan Shams, Yu‐Chun Hsu et al.|Scientific Reports|2025Cited by 9
Clinical implications of tumor-based next-generation sequencing in ovarian cancer.Katherine Foster, Anil K. Sood, Kenna Shaw et al.|Journal of Clinical Oncology|2022Cited by 1
How to train your robot: Artificial intelligence predicts treatment response in ovarian cancer (069)Deanna Glassman, Anil K. Sood, Katelyn F. Handley et al.|Gynecologic Oncology|2022Cited by 1
Systematic high-throughput combination drug screen to enhance poly (ADP-ribose) polymerase (PARP) inhibitor efficacy in ovarian cancer.Katherine Foster, Anil K. Sood, Reid T. Powell et al.|Journal of Clinical Oncology|2023Cited by 1